NeoMed Management, a Norway-based life sciences venture capital firm, has completed the first closing for its fourth fund at €38m ($50.3m).
The final fundraising target is €100m, which the firm expects to achieve by the summer.
NeoMed makes first life science fund close
NeoMed Management, a Norway-based life sciences venture capital firm, has completed the first closing for its fourth fund at €38m ($50.3m).
The final fundraising target is €100m, which the firm expects to achieve by the summer.